Tiger Brokers

BRIEF-Eli Lilly Spokesperson Says No One Should Be Mass-Compounding Or Selling Knockoff Glp-1 Products Regardless Of How They’re Administered

Reuters
Feb 08
BRIEF-Eli Lilly Spokesperson Says No One Should Be Mass-Compounding Or Selling Knockoff Glp-1 Products Regardless Of How They’re Administered

Feb 7 (Reuters) - Eli Lilly and Co LLY.N:

  • ELI LILLY SOKESPERSON: LOOK FORWARD TO DECISIVE STEPS FDA HAS ANNOUNCED IT WILL TAKE, AND WE URGE OTHER REGULATORS AND LAW ENFORCEMENT TO DO THE SAME

  • ELI LILLY SPOKESPERSON: NO ONE SHOULD BE MASS-COMPOUNDING OR SELLING KNOCKOFF GLP-1 PRODUCTS REGARDLESS OF HOW THEY’RE ADMINISTERED

Source text: [ID:]

Further company coverage: LLY.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10